| Document Date: 2014-06-28 10:46:49
Open Document File Size: 42,24 KBShare Result on Facebook
City TOKYO / Development Platforms Parsippany / / Company Press Release Daiichi Sankyo Europe GmbH / Daiichi Sankyo Group / Daiichi Sankyo Company Limited / Plexxikon Inc. / Genentech / / Country Japan / United States / / Currency USD / / / Event Business Partnership / M&A / Company Expansion / FDA Phase / / Facility To Join Daiichi Sankyo Group Strategic Acquisition Strengthens Daiichi Sankyo Oncology Pipeline / / / IndustryTerm late-stage oncology product / pharmaceuticals / molecule pharmaceuticals / pharmaceutical / / MedicalCondition previously untreated metastatic melanoma / rheumatoid arthritis / malignant melanoma / CNS disorders / metastatic cancer / neuro-inflammatory and cardio-renal diseases / human disease / / Person Joji Nakayama / / / Position CEO / / Product PLX4032 / / ProvinceOrState New Jersey / California / / Technology Drug Discovery / / URL www.tcpdf.org / www.daiichi-sankyo.eu / /
SocialTag |
Press Release Daiichi Sankyo Europe GmbH Zielstattstrasse[removed]Munich · Germany Phone +[removed]